Dr Abhishek Aggarwal
MBBS MS MCh
Associate Director GI Oncosurgery
BLK Max Superspeciality Hospital, Delhi
Dr. Abhishek Aggarwal is a distinguished Gastrointestinal (GI), Hepato-Pancreato-Biliary (HPB), and GI Cancer Surgeon committed to delivering advanced surgical care with precision, compassion, and excellence. Widely recognized as the Best GI & HPB Surgeon in Rajendra Place, he specializes in the diagnosis and treatment of complex disorders involving the digestive tract, liver, pancreas, gallbladder, and biliary system.
With extensive experience in managing both benign and malignant gastrointestinal conditions, Dr. Aggarwal combines cutting-edge surgical techniques with evidence-based medical practices to provide the highest standard of patient care. His expertise in minimally invasive, laparoscopic, and advanced oncological surgeries enables patients to benefit from safer procedures, reduced recovery time, and improved outcomes. His patient-first philosophy, ethical medical approach, and commitment to surgical excellence have earned him the trust of patients from across Delhi NCR and India.
Dr. Abhishek Aggarwal possesses an exceptional academic background and advanced surgical training in the field of Gastrointestinal and HPB Surgery.
All India Institute of Medical Sciences
MCh, Surgical Gastroenterology
2015 – 2018
SMS Medical College Jaipur
Master's Degree, MS (GENERAL SURGERY)
2010 – 2013
Dr D Y PATIL MEDICAL COLLEGE PUNE
M.B.B.S
2003 – 2009
Apeejay school pitampura delhi
1998 – 2003
Experience
Associate Director GI HPB Oncosurgery
BLK - Max Super Speciality Hospital · Full-time
Jul 2025 - Present · 1 yr
Rajiv Gandhi Cancer Institute and Research Centre
Consultant GI-HPB Oncosurgery
Jan 2020 - Mar 2025 · 5 yrs 3 mos
Fellow GI and HPB Oncosurgery
Jan 2019 - Dec 2019 · 1 yr
Senior Resident (Surgical Gastroenterology)
AIIMS (All India Institute of Medical Sciences, New Delhi) · Full-time
Jul 2015 - Jun 2018 · 3 yrs
Dr. Abhishek Aggarwal has consistently contributed to the field of Gastrointestinal and HPB Surgery through clinical research, academic publications, and scientific presentations.
Reasearch and publications
1. Meena L. N. , Aggarwal Abhishek , Jain Sanchit. Cotyledonoid Leiomyoma of Uterus. The Journal of Obstetrics and Gynecology of India (March–April 2014) 64(2):146–147
2. Abhishek Aggarwal, Sanchit Jain, LN Meena, Sumita A Jain, Lakshman : Validation of Boey’s score in predicting morbidity and mortality in peptic perforation peritonitis in North western India. Tropical Gastroenterology 2015;36(4):256–260
3. Sanchit Jain, Abhishek Agarwal, Lakshman Agarwal, Laxmi Narayan Meena, Sumita Jain. Randomized trial to compare efficacy of polyester mosquito net mesh with polypropylene mesh in inguinal hernia surgery in north western India.Arch Clin Exp Surg 2016;5: 200-205.
4. Razik A, Madhusudhan KS, Aggarwal A, Panwar R, Srivastava DN. Gastrointestinal Stromal Tumor of the Jejunum With Active Bleeding Demonstrated on Dual-Energy MDCT Angiography: A Case Report. Curr Probl Diagn Radiol. 2019 May-Jun;48(3):298-301.
5. Hyperthermic intraperitoneal chemotherapy in gall bladder cancer: a pilot study(Abstract). A. Aggarwal N. R. Dash, S. Pal, A. Sharma, S. Deo, P. Sahni. HPB 2018, 20 (S2), S295- S332.
6. Goel S, Aggarwal A, Iqbal A, Gupta M, Rao A, Singh S. 18-FDG PET-CT should be included in preoperative staging of gall bladder cancer. Eur J Surg Oncol 2020;46: 1711-1716
7. Sayed AI, Goel S, Aggarwal A, Singh S. Robot assisted minimally invasive esophagectomy: safety, perioperative morbidity and short-term oncological outcome-a single institution experience. J Robot Surg. 2021 Jul 6. doi: 10.1007/s11701-021-01274-9.
8. Singh S, Goel S, Aggarwal A, Iqbal A, Hazarika D, Talwar V. Combination of portal vein embolization and neoadjuvant chemotherapy for locally advanced gallbladder cancer requiring extended hepatectomy - A novel approach. Indian J Gastroenterol. 2021 Dec;40(6):580-589.
9. Iqbal SA, Goel S, Aggarwal A, Gupta N, Gupta M, Durga G, Talwar V, Singh S. Use of 18F Fluorodeoxyglucose Positron Emission Tomography Computed Tomography in Assessing Response to Neoadjuvant Chemoradiation and Its Impact on Survival in Esophageal Squamous Cell Carcinoma. J Gastrointest Cancer. 2020
10. Goel S, Aggarwal A, Iqbal A, Talwar V, Mitra S, Singh S. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India. World J Gastroenterol. 2021 Dec 7;27(45):7813-7830.
11. Aggarwal A, Goel S, Sayed AI, Goel V, Talwar V, Singh S. Interaortocaval Lymph Node Metastasis in Gall Bladder Cancer: Is It Regional Node or Metastatic Disease? J Gastrointest Cancer. 2023 Feb .
12. Timing of curative resection in incidental gall bladder cancer: does it really matter?Dr Suchita Chowdhury, DrNB,SurgicalOncology? Dr Abhishek Aggarwal, MCh GI Surgery ? Dr Shaifali Goel, DNB, GI Surgery ? Dr Sayed Assif Iqbal, DNB, Surgical Oncology ? Dr Shivendra Singh, MCh, GI Surgery. HPB 2024
13. Chowdhury S, Aggarwal A, Goel S, Goel V, Talwar V, Singh S. Gastric cancer with limited peritoneal metastasis: Role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Indian J Gastroenterol. 2025 Oct;44(5):692-699.
14. Singh S, Aggarwal A, Goel S, Iqbal SA, Talwar V. Segment 4b/5 versus Wedge Resection for Gallbladder Adenocarcinoma: A Randomized Controlled Trial. Ann Surg. 2025 Sep 25
15. Lahiri A, Goel S, Aggarwal A, Iqbal SA, Mehta A, Batra U, Sethi J, Singh S. Robotic versus open esophagectomy: a propensity score-matched analysis from a tertiary cancer center in India. J Robot Surg. 2025 Oct 10;19(1):672.
16. Aggarwal M, Aggarwal A, Goel S, Goyal S, Garg P, Gupta G, Singh S. Prognostic Factors and Long-term Outcomes in Patients With Colorectal Peritoneal Metastases Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Cohort Study From a Tertiary Care Center in India. Dis Colon Rectum. 2026 Jan 1;69(1):42-52.
17. Jaganathan K, Goel S, Aggarwal A, Iqbal A, Garg P, Singh S. Role of 18FDG PET-CT & MRI for Predicting Response to Neo-Adjuvant Therapy in Rectal Cancer. J Gastrointest Cancer. 2025 Nov 29;56(1):230
18. Lahiri A, Chowdhury S, Goel S, Assif Iqbal S, Aggarwal A, Garg P, Goel V, Talwar V, Sethi J, Singh S. Neoadjuvant therapy in gall bladder cancer improves resectability and survival: a prospective study. HPB (Oxford). 2026 Feb 2:S1365-182X(26)00016-X
Awards and presentations
1. Best oral paper award at state chapter (Rajasthan), ASICON( Association of surgeons of India annual conference) 2011.
2. Presented a paper titled “Enucleation and cavito-jejunostomy in patients with Insulinoma of the head of pancreas” at IHPBA Indiaannual conference in January 2018, Pune.
3. Presnted a poster , “Safety and feasibility of hyperthermic intrapeirtoneal chemotherapy (HIPEC) in resectable gall bladder cancer: A pilot study” at ESSO – ISPSSM international conference on HIPEC 2018 , AIIMS, Delhi.
4. Presented a poster titled “ Non hepatic surgery in chronic liver disease: has surgery become any safer?” at ILS( International liver symposium) conducted by Medanta institute of liver transplantation in March 2018, Delhi.
5. Presnted a “Talking poster” titled , “Role of hyperthermic intrapeirtoneal chemotherapy (HIPEC) gall bladder cancer” at IHPBA world congress in Geneva, 2018.
6. Role of PET scan in gall bladder carcinoma. IHPBA India annual conference 2019, Jaipur. – special mention poster award.
7. Presented a poster titled “Role of radical surgery in gall bladder cancer patients with interaortocaval lymph node metastases” at IHPBA India annual conference 2021 held online.
8. Participated as faculty in 23rd ACRSI instructional course 2019, organised by Sir Gangaram hopsital Delhi.
9. Participated as panelist in Oncology forum annual meeting in December 2019, Delhi.
10. Participated as faculty in national GI Oncology webinar series organised by Max institute of cancer care on 15/12/2021.
His multidisciplinary approach ensures personalized treatment plans tailored to each patient's condition, resulting in superior clinical outcomes.
Dr. Abhishek Aggarwal envisions becoming a trusted center of excellence for Gastrointestinal and HPB Surgery by providing world-class healthcare services through innovation, expertise, and compassionate patient care.
His vision is to transform the management of gastrointestinal and hepatobiliary diseases by integrating advanced surgical technologies, minimally invasive procedures, and evidence-based treatment protocols. Through continuous learning and adoption of modern surgical techniques, he strives to improve patient outcomes and set new standards in GI and HPB surgical care.
He believes in delivering healthcare that is not only clinically advanced but also accessible, ethical, and patient-focused.
We use advanced laparoscopic and robotic surgery for precise treatment, minimal pain, and faster recovery.
We create personalized treatment plans based on medical history, diagnostics, and overall health for best outcomes.
Our team collaborates across oncology specialties to deliver coordinated, effective, and comprehensive cancer care.
With extensive experience, we ensure high success rates, minimal complications, and maximum patient safety.
Minimally invasive procedures and recovery protocols ensure faster healing, shorter stays, and quicker return to normal life.
We use modern diagnostic tools and screening methods to detect cancer early, enabling timely treatment and improved patient outcomes.
